A record for the reading desk
Bremelanotide
Aliases: Vyleesi
The recorded fields, their references, and a question worth keeping.
- Status
- Approved product
- Evidence label
- Randomized evidence
- Index topics
- Sexual health
- Status as of
Record / 01
Recorded fields
- Mechanism
- Melanocortin-receptor agonist.
- Evidence
- Randomized trials.
- Limitations
- Exclude medical, relationship and drug causes; not performance enhancement.
- Safety
- Uncontrolled hypertension or known cardiovascular disease: contraindicated.
- Route context
- Subcutaneous injection.
- Approval scope
- Vyleesi: eligible premenopausal women with distressing acquired generalized low-desire disorder.
Reasoning / 02
A note for your reading
An ordered scale tells you which position comes before another. It does not automatically tell you that every step covers the same distance. Imagine labels arranged from low to high without a rule defining the gaps between them. Moving up a label would have a clear direction, but calling that movement twice as large as another would need more justification. Before interpreting arithmetic built from such labels, ask what their spacing means. This keeps the ordering useful while making clear which further claims depend on assumptions about distance.
Keep asking / 03
Three questions to carry forward
- Does this scale define equal distances or only an order among labels?
- What justifies treating a movement between labels as a measurable amount?
- Which conclusions remain valid if the spacing between positions is unknown?
Trace the record / 04
References
- VYLEESI
NLM · Checked
- Kingsberg trials
PubMed · Checked